NTRA Q3 2022 Earnings — Natera, Inc. Revenue & Financial Results | Market Cap Arena

NTRANatera, Inc.

$29B

Q3 2022 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$211M+33.2% YoY

Gross Profit

$94M44.7% margin

Operating Income

-$119M-56.5% margin

Net Income

-$121M-57.7% margin

EPS (Diluted)

$-1.25

QoQ Revenue Growth

+6.3%

Cash Flow

Operating Cash Flow

-$102M

Free Cash Flow

-$114M

Stock-Based Comp.

$40M

Balance Sheet

Total Assets

$1.0B

Total Liabilities

$647M

Stockholders' Equity

$362M

Cash & Equivalents

$57M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$211M	$158M	+33.2%
Gross Profit	$94M	$77M	+22.6%
Operating Income	-$119M	-$150M	+20.7%
Net Income	-$121M	-$151M	+19.7%

Revenue Segments

Product

$200M95%

Licensing and other

$11M5%

Geographic Segments

United States

$197M94%

Asia Pacific and Other

$7M4%

Europe, Middle East, India, Africa

$5M2%

Americas, excluding U.S.

$1M1%